LifeStance Health Group, Inc.

LFST Healthcare Medical Care Facilities

LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 26.1%, EPS grew 700.0%, free cash flow grew 55.2% and total debt fell 5.08%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

11.74 0.63 −5.09%
Market cap
$4.7B
P/E
88.3×
Fwd P/E
58.5×
Dividend yield
—
F-score
8/9
Altman Z
2.65
Beneish M
−2.96
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 283.87
Piotroski F-Score
— — — 5 4 4 6 8
Altman Z-Score
— — — 4.59 1.35 2.25 2.54 2.65
P/S ratio
— 14.96 14.96 4.67 1.92 2.75 2.23 1.91
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 32.61 24.70
Altman Z″-Score (non-manufacturers)
— (2.60) 1.87 3.15 1.10 0.50 1.16 1.71
Beneish M-Score
— — (1.48) (2.82) (2.75) (2.73) (2.83) (2.96)
P/Operating CF
— 675.27 675.27 101.78 45.99 172.84 44.84 47.21
P/B ratio
— 7.01 7.01 2.02 1.09 2.03 1.93 1.79
EV/Sales
— 15.74 15.74 4.69 2.06 2.94 2.33 1.92
EV/EBITDA
— 147.69 147.69 0.00 0.00 0.00 71.20 34.22
EV/FCF
— (166.98) (166.98) (36.76) (66.82) (54.08) 34.07 24.86
Current Ratio
— 0.50 1.00 2.28 1.33 1.11 1.37 1.65
Net Debt/EBITDA
— 3.44 7.24 (0.04) (0.84) (1.89) 3.05 0.22
Debt/Equity
— (0.48) 0.36 0.10 0.15 0.20 0.19 0.17
ROE
— (14.16%) (74.88%) (27.05%) (14.07%) (12.64%) (4.00%) 0.65%
ROA
— (41.96%) (33.65%) (19.67%) (10.51%) (8.70%) (2.72%) 0.45%
ROIC
— 0.00% 0.72% (11.51%) (8.03%) (7.25%) (1.26%) 0.98%
Return on Tangible Assets
— 1,142.44% (521.39%) (113.89%) (85.74%) (88.24%) (23.01%) 2.97%
Average Days of Receivables
— 32.00 42.29 41.60 42.83 43.36 38.46 24.53
Earnings Yield
— (0.71%) (0.71%) (9.65%) (13.12%) (6.46%) (2.11%) 0.35%
Free Cash Flow Yield
— (0.63%) (0.63%) (2.73%) (1.60%) (1.98%) 3.07% 4.05%
Free Cash Flow per Share
— 0.01 (0.15) (0.26) (0.07) (0.16) 0.23 0.29
Book value per Share
— (0.45) 3.30 4.72 4.27 3.89 3.81 3.94
Free Cash Flow
— 2.73 (46.60) (85.07) (26.47) (57.40) 85.69 110.03
EV/EBIT
— 789.14 789.14 0.00 0.00 0.00 0.00 113.25
Other line items

Show all line items

Columns are period end dates